Dendreon Corp (DNDN) Return on Investment ROI from the third quarter of 2014 to third quarter of 2013 and for the year 2014, average high and low, overall ranking from Sep 30 2014 to Sep 30 2013 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dendreon Corp  (DNDN)


Dendreon's ROI from its third quarter of 2014 to the third quarter of 2013 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Dendreon's ROI in the third quarter of 2014?
Dendreon Corp recorded a cumulative net loss of $-162 million during 12 months ending in the third quarter of 2014, resulting in a negative return on investment (ROI) of -55.2%.

Within the Healthcare sector 277 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2014 from 0 to 3616.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Investment Change TTM -42.49 % -41.97 % -41.95 % -39.26 % -37.89 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 267 281 298 331 411
Return On Investment (TTM) -55.2 % -62.84 % -69.36 % -67.44 % -48.22 %
DNDN's Overall Ranking # 3616 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -10.91 % -12.27 % -14.43 % -14 % -10.12 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -162 -208 -261 -297 -247

DNDN Company Profile >> Back to DNDN Roi Comparisons >> See Annual DNDN Return On Investment



Return On Investment DNDN's Ranking
Within: No.
Industry # 25
Sector # 278
Overall # 3616

Return On Investment Statistics
High Average Low
-47.97 %
-57.38 %
-68.9 %
(Sep 30 2013)   (Mar 31 2014)







Financial Statements
Dendreon's III. Quarter Investments $ 267 Millions DNDN's Balance sheet
Dendreon's III. Quarter Income $ -22 Millions Quarterly DNDN's Income Statement
DNDN's Income by Division See DNDN's Income by Division


DNDN Annual Return On Investment (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2011)
2011		 (Dec 31 2008)
2010
Total Investments in Millions 331 617 1,014 572 0
Y / Y Investment Growth -46.43 % -39.16 % 77.2 % - -
Net Income in Millions -297 -394 -338 -72 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -89.77 % -63.78 % -33.3 % -12.51 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DNDN's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DNDN's Competitors
Subscribers only: Roi for Dendreon's Suppliers
Subscribers only: Return On Investment for DNDN's Customers

Other Ratios
DNDN's Roa DNDN's Inventory Turnover Ratio DNDN's Growth Rates DNDN's Dividend Statistics
DNDN's Profitability Ratios DNDN's Asset Turnover Ratio DNDN's Dividend Growth
DNDN's Roe DNDN's Valuation Ratios DNDN's Financial Strength Ratios DNDN's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2014, within Healthcare Sector ROI

Date modified: 2026-09-08T15:07:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.